2012 annual financial data
Vistagen Therapeutics 2012 Net margin
Vistagen Therapeutics 2012 net margin with verified reported values.
Direct answer
Net margin was -909.66%.
Operating income was -9,043,400 USD and net income was -12,209,500 USD.
Operating cash flow was -3,565,800 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,342,200 USD
- Operating income
- -9,043,400 USD
- Net income
- -12,209,500 USD
- Operating cash flow
- -3,565,800 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Vistagen Therapeutics financial years